139 related articles for article (PubMed ID: 33357145)
1. Expression of syndecan-1 in oral cavity squamous cell carcinoma.
Woźniak M; Nahajowski M; Hnitecka S; Rutkowska M; Nowak M; Mitelsztet P; Szkudlarek D; Makuch S
J Histotechnol; 2021 Mar; 44(1):46-51. PubMed ID: 33357145
[TBL] [Abstract][Full Text] [Related]
2. Follistatin-related protein 1 interacting partner of Syndecan-1 promotes an aggressive phenotype on Oral Squamous cell carcinoma (OSCC) models.
Zandonadi FS; Yokoo S; Granato DC; Rivera C; Macedo CCS; Soares CD; Carnielli CM; Domingues RR; Pauletti BA; Consonni SR; Colleta RD; Paes Leme AF
J Proteomics; 2022 Mar; 254():104474. PubMed ID: 34990821
[TBL] [Abstract][Full Text] [Related]
3. Comparative E-cadherin and syndecan-1 protein expression in human and canine oral squamous cell carcinoma.
Tabtieang SP; Paphussaro W; Rungsipipat A; Kunnasut N; Ploypetch S; Phattarataratip E; Suriyaphol G
Acta Vet Hung; 2024 Jan; 71(3-4):202-209. PubMed ID: 38193945
[TBL] [Abstract][Full Text] [Related]
4. Expression of syndecan-1 in different grades of oral squamous cell carcinoma: An immunohistochemical study.
Shetty PK; Gonsalves N; Desai D; Pandit S; Aradhya C; Shahid M; Shubhalakshmi ; Shetty SJ
J Cancer Res Ther; 2022 Dec; 18(Supplement):S191-S196. PubMed ID: 36510963
[TBL] [Abstract][Full Text] [Related]
5. In reference to quantitative analysis of syndecan-1 expression in dysplasia and squamous cell carcinoma of the oral cavity.
Saussez S
Laryngoscope; 2008 May; 118(5):944-5; author reply 945. PubMed ID: 18449017
[No Abstract] [Full Text] [Related]
6. Epithelial and stromal syndecan-1 and -2 are distinctly expressed in oral- and cutaneous squamous cell carcinomas.
Ahmed Haji Omar A; Haglund C; Virolainen S; Häyry V; Atula T; Kontio R; Rihtniemi J; Pihakari A; Salo T; Hagström J; Sorsa T
J Oral Pathol Med; 2013 May; 42(5):389-95. PubMed ID: 23278563
[TBL] [Abstract][Full Text] [Related]
7. Laminin-derived peptide AG73 regulates migration, invasion, and protease activity of human oral squamous cell carcinoma cells through syndecan-1 and beta1 integrin.
Siqueira AS; Gama-de-Souza LN; Arnaud MV; Pinheiro JJ; Jaeger RG
Tumour Biol; 2010 Jan; 31(1):46-58. PubMed ID: 20237901
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of syndecan-1 expression in dysplasia and squamous cell carcinoma of the oral cavity.
Jackson LL; Wade Z; Hessler RB; Abdelsayed R; Rogers JB; Gourin CG
Laryngoscope; 2007 May; 117(5):868-71. PubMed ID: 17473685
[TBL] [Abstract][Full Text] [Related]
9. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma.
Mukunyadzi P; Liu K; Hanna EY; Suen JY; Fan CY
Mod Pathol; 2003 Aug; 16(8):796-801. PubMed ID: 12920224
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
[TBL] [Abstract][Full Text] [Related]
11. Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous cell carcinoma.
Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Takamori K; Igawa K; Yoshida M; Fukuyama H; Takahashi T; Sakoda S
J Oral Pathol Med; 2006 May; 35(5):301-6. PubMed ID: 16630294
[TBL] [Abstract][Full Text] [Related]
12. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of FOXD1 is associated with cervical node metastasis and unfavorable prognosis in oral squamous cell carcinoma.
Li Z; Yan T; Wu X; Zhang W; Li J; Wang L; Yang J
J Oral Pathol Med; 2020 Nov; 49(10):1030-1036. PubMed ID: 32808339
[TBL] [Abstract][Full Text] [Related]
14. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
[TBL] [Abstract][Full Text] [Related]
15. Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck.
Inki P; Joensuu H; Grénman R; Klemi P; Jalkanen M
Br J Cancer; 1994 Aug; 70(2):319-23. PubMed ID: 8054282
[TBL] [Abstract][Full Text] [Related]
16. Pokemon proto-oncogene in oral cancer: potential role in the early phase of tumorigenesis.
Sartini D; Lo Muzio L; Morganti S; Pozzi V; Di Ruscio G; Rocchetti R; Rubini C; Santarelli A; Emanuelli M
Oral Dis; 2015 May; 21(4):462-9. PubMed ID: 25439053
[TBL] [Abstract][Full Text] [Related]
17. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
Zhang J; Ling T; Wu H; Wang K
J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482
[TBL] [Abstract][Full Text] [Related]
18. Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma.
Rintala M; Inki P; Klemi P; Jalkanen M; Grénman S
Gynecol Oncol; 1999 Dec; 75(3):372-8. PubMed ID: 10600292
[TBL] [Abstract][Full Text] [Related]
19. Detection of Epstein-Barr virus encoded small RNA genes in oral squamous cell carcinoma and non-cancerous oral cavity samples.
Zebardast A; Yahyapour Y; Majidi MS; Chehrazi M; Sadeghi F
BMC Oral Health; 2021 Oct; 21(1):502. PubMed ID: 34615503
[TBL] [Abstract][Full Text] [Related]
20. Salivary Chemical Barrier Proteins in Oral Squamous Cell Carcinoma-Alterations in the Defense Mechanism of the Oral Cavity.
Kalló G; Bertalan PM; Márton I; Kiss C; Csősz É
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
